Vol.24, No.2, 2022, pp.349-356, doi:10.32604/oncologie.2022.022436
OPEN ACCESS
CASE REPORT
Surgery Combined with Molecular Targeted Therapy Successfully Treated Giant Esophageal Gastrointestinal Stromal Tumor
  • Mengjie Li1,#, Jun Wei2,#, Guihua Xu3,#, Ying Liu3,*, Jian Zhu3,*
1 Department of Respiratory Oncology, Renmin Hospital of Qingxian, Cangzhou, 062650, China
2 Department of the First Surgery, Wuhan Jin-Yin-Tan Hospital, Wuhan, 430011, China
3 Department of Thoracic Cardiovascular Surgery, General Hospital of Central Theater Command of the People’s Liberation Army, Wuhan, 430070, China
* Corresponding Authors: Jian Zhu. Email: ; Ying Liu. Email:
# These authors contributed equally to this work and should be considered as co-first authors
Received 10 March 2022; Accepted 06 May 2022; Issue published 29 June 2022
Abstract
Gastrointestinal stromal tumors (GISTs) are rare neoplasms arising from mesenchymal cells of the digestive tract and abdomen. Only a few isolated cases of giant esophageal GISTs (greater than 5 cm in size) have been reported with clinical features and surgical methods. Radical esophagectomy with negative margins, followed by gastric tube reconstruction, is recommended for giant esophageal GISTs. However, patients undergoing this type of surgery experienced a sharp decrease in food intake (due to the removal of most of the stomach) and were prone to eating regurgitation, resulting in poor quality of life. We describe the case of a 65-year-old man with a 16.3-cm giant esophageal GIST. The results of frozen quick pathology during the operation indicated an esophageal stromal tumor. Only resection of the esophageal mass was performed upon no consent for esophageal resection by family members. The patient received oral treatment with 400 mg of imatinib once daily after the operation. After 3 years of follow-up, the patient showed no signs of recurrence or metastasis. The successful management of this case suggests that molecular targeted therapy after surgery would avoid giant esophageal GIST recurrence. Therefore, giant esophageal GISTs probably do not need radical esophagectomy with negative margins, followed by gastric tube reconstruction.
Keywords
Molecular targeted therapy; giant esophageal gastrointestinal stromal tumor; operational styles; imatinib; case report
Cite This Article
Li, M., Wei, J., Xu, G., Liu, Y., Zhu, J. (2022). Surgery Combined with Molecular Targeted Therapy Successfully Treated Giant Esophageal Gastrointestinal Stromal Tumor. Oncologie, 24(2), 349–356.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.